Levosulpiride-induced parkinsonism in a young adult: A case report
DOI:
https://doi.org/10.22516/25007440.1519Keywords:
Dyspepsia, parkinsonism, extrapyramidal disorders, drug-related side effects and adverse reactions, pharmacovigilance, case reportsAbstract
Background: Levosulpiride is a selective dopamine D2 receptor antagonist with prokinetic activity that is widely used in the management of functional dyspepsia and other gastrointestinal motility disorders. Although its action is considered predominantly peripheral, its affinity for central dopaminergic receptors may be associated with neurologic adverse effects.
Case Report: The case of a young patient who developed severe extrapyramidal symptoms consistent with parkinsonism after receiving therapeutic doses of levosulpiride for 10 days is presented. Causality assessment using the Naranjo scale indicated a probable relationship between drug exposure and the adverse event, and a diagnosis of drug-induced parkinsonism was established. Treatment with biperiden was required, followed by progressive resolution of symptoms.
Conclusions: This case highlights that levosulpiride, despite its widespread use in gastroenterology and generally favorable safety profile, may induce drug-induced parkinsonism even in young patients without identifiable risk factors following short-term exposure at standard doses. This underscores the importance of pharmacovigilance and early recognition of neurologic adverse effects in clinical practice.
Downloads
References
Serra J. Levosulpirida en el manejo de la dispepsia funcional y la gastroparesia. Gastroenterol Hepatol. 2010;33(8):586-90. https://doi.org/10.1016/j.gastrohep.2010.07.002
Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F. Review article: Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther. 2004;19(4):379-90. https://doi.org/10.1111/j.1365-2036.2004.01867.x
Gowtham A, Sulthana B, Sacheendran D, Ovallath S. Levosulpiride induced parkinsonism and other movement disorders. Open Access J Neurol Neurosurg. 2017;5(3):42-6. https://doi.org/10.19080/OAJNN.2017.05.555665
Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: Pathophysiology and mechanisms of induction. Can J Psychiatry. 2005;50:541-47. https://doi.org/10.1177/070674370505000907
Shin HW, Chung SJ. Drug-induced parkinsonism. J Clin Neurol. 2012;8(1):15-21. https://doi.org/10.3988/jcn.2012.8.1.15
Miller LG, Jankovic J. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990;83(5):525-32. https://doi.org/10.1097/00007611-199005000-00011
Thanvi B, Treadwell J. Drug-induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J. 2009;85(1004):322-26. https://doi.org/10.1136/pgmj.2008.073312
Mathew T, Nadimpally US, Prabhu AD, Nadig R. Drug-induced parkinsonism on the rise: beware of levosulpiride and its combinations with proton pump inhibitors. Neurol India. 2017;65(1):173-74. https://doi.org/10.4103/0028-3886.198175
Joe J. Levosulpiride-induced neurological adverse effects: a prospective study from a tertiary care center. Ann Indian Acad Neurol. 2020;23(2):174-76. https://doi.org/10.4103/aian.AIAN_449_18
Montastruc JL, Llau ME, Rascol O, Senard JM. Drug-induced parkinsonism: a review. Fundam Clin Pharmacol. 1994;8(4):293-306. https://doi.org/10.1111/j.1472-8206.1994.tb00808.x
Shin HW, Kim MJ, Kim JS, Lee MC, Chung S. Levosulpiride-induced movement disorders. Mov Disord. 2009;24(15):2249-53. https://doi.org/10.1002/mds.22805
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45. https://doi.org/10.1038/clpt.1981.154
López-Sendón JL, Mena MA, de Yébenes JG. Drug-induced parkinsonism in the elderly: incidence, management and prevention. Drugs Aging. 2012;29(2):105-118. https://doi.org/10.2165/11598540-000000000-00000
Choudhury S, Chatterjee K, Singh R, Shubham S, Trivedi S, Chatterjee S, et al. Levosulpiride-induced movement disorders: Indian scenario. J Pharmacol Pharmacother. 2017;8(4):177-81. https://doi.org/10.4103/jpp.JPP_32_17
Vaiman EE, Shnayder NA, Khasanova AK, Strelnik AI, Gayduk AJ, Al-Zamil M, et al. Pathophysiological mechanisms of antipsychotic-induced parkinsonism. Biomedicines. 2022;10(8):2010. https://doi.org/10.3390/biomedicines10082010
Tandon VR, Ismail SH, Singh A. Fixed drug combination (levosulpiride and rabeprazole)-induced atypical parkinsonian disorders with associated anxiety and low-lying depression. Indian J Pharmacol. 2024;56(1):52-4. https://doi.org/10.4103/ijp.ijp_929_21
Conn H, Jankovic J. Drug-induced parkinsonism: diagnosis and treatment. Expert Opin Drug Saf. 2024;23(12):1503-13. https://doi.org/10.1080/14740338.2024.2418950
Mathews M, Gratz S, Adetunji B, George V, Mathews M, Basil B. Antipsychotic-induced movement disorders: evaluation and treatment. Psychiatry (Edgmont). 2005;2(3):36-41.
Instituto Nacional de Vigilancia de Medicamentos y Alimentos. Resolución 2024015321 del 8 de abril de 2024. Por la cual se establece el reglamento relativo al contenido y periodicidad de los reportes de eventos adversos y los programas de farmacovigilancia para titulares de registro sanitario y fabricantes. Bogotá: INVIMA; 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista colombiana de Gastroenterología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

| Article metrics | |
|---|---|
| Abstract views | 1 |
| Galley views | 0 |
| PDF Views | 0 |
| HTML views | 0 |
| Other views | 0 |














